SKI Market

Indian Indices

Sensex

85,041.45 -367.25
( -0.43%)

Global Indices

Nasdaq

48,728.27 -23.90
(-0.05%)

Dow Jones

6,949.98 -3.07
(-0.04%)

Hang Seng

50,641.54 233.75
(0.46%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.83 0.26
(0.29%)

EUR-INR

105.77 0.25
(0.24%)

GBP-INR

121.29 0.43
(0.36%)

JPY-INR

0.58 0.00
(0.43%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Abbott India Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500488

INE358A01014

1887.4870588

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ABBOTINDIA

40.66

61352.36

EPS(TTM)

Face Value()

Div & Yield %

710.09

1.65

Back

Anmol India standalone net profit declines 93.07% in the September 2025 quarter

Nov 14,2025

Net profit of Anmol India declined 93.07% to Rs 0.07 crore in the quarter ended September 2025 as against Rs 1.01 crore during the previous quarter ended September 2024. Sales rose 22.88% to Rs 228.29 crore in the quarter ended September 2025 as against Rs 185.78 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	228.29	185.78	23
OPM %	0.42	1.42	-
PBDT	0.27	1.45	-81
PBT	0.09	1.35	-93
NP	0.07	1.01	-93

85,041.45 -367.25 ( -0.43%)

48,728.27 -23.90 (-0.05%)

6,949.98 -3.07 (-0.04%)

50,641.54 233.75 (0.46%)

9,870.68 -18.54 (-0.19%)

89.83 0.26 (0.29%)

105.77 0.25 (0.24%)

121.29 0.43 (0.36%)

0.58 0.00 (0.43%)